| Literature DB >> 29879172 |
Zachary P Metz1, Tong Ding1, David J Baumler1,2,3.
Abstract
Listeria monocytogenes is a microorganism of great concern for the food industry and the cause of human foodborne disease. Therefore, novel methods of control are needed, and systems biology is one such approach to identify them. Using a combination of computational techniques and laboratory methods, genome-scale metabolic models (GEMs) can be created, validated, and used to simulate growth environments and discern metabolic capabilities of microbes of interest, including L. monocytogenes. The objective of the work presented here was to generate GEMs for six different strains of L. monocytogenes, and to both qualitatively and quantitatively validate these GEMs with experimental data to examine the diversity of metabolic capabilities of numerous strains from the three different serovar groups most associated with foodborne outbreaks and human disease. Following qualitative validation, 57 of the 95 carbon sources tested experimentally were present in the GEMs, and; therefore, these were the compounds from which comparisons could be drawn. Of these 57 compounds, agreement between in silico predictions and in vitro results for carbon source utilization ranged from 80.7% to 91.2% between strains. Nutrient utilization agreement between in silico predictions and in vitro results were also conducted for numerous nitrogen, phosphorous, and sulfur sources. Additionally, quantitative validation showed that the L. monocytogenes GEMs were able to generate in silico predictions for growth rate and growth yield that were strongly and significantly (p < 0.0013 and p < 0.0015, respectively) correlated with experimental results. These findings are significant because they show that these GEMs for L. monocytogenes are comparable to published GEMs of other organisms for agreement between in silico predictions and in vitro results. Therefore, as with the other GEMs, namely those for Escherichia coli, Staphylococcus aureus, Vibrio vulnificus, and Salmonella spp., they can be used to determine new methods of growth control and disease treatment.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29879172 PMCID: PMC6012718 DOI: 10.1371/journal.pone.0198584
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Numerical genome comparison of the six chosen strains of L. monocytogenes.
| Source | Genes (% Shared) | Unique Genes (% of Genome) | Serovar | Serovar Specific Genes | |
|---|---|---|---|---|---|
| J2-031 | Animal isolate (bovine) 1996 | 3,009 (86.6%) | 49 (1.63%) | 1/2a | 53 |
| JO161 | Human epidemic 2000 | 3,024 (86.1%) | 65 (2.15%) | ||
| J2-064 | Food epidemic 1994 (Illinois) | 2,938 (88.7%) | 16 (0.54%) | 1/2b | 13 |
| R2-502 | Animal isolate (bovine) 1989 | 3,069 (84.9%) | 57 (1.86%) | ||
| F2365 | Food epidemic 1985 (L.A) | 2,907 (89.6%) | 32 (1.10%) | 4b | 26 |
| ScottA | Human epidemic 1993 | 3,016 (86.4%) | 73 (2.42%) |
Gene, metabolite, and reactions contained in each version of the GEMs.
| Strain | Genes (% of Genome) | Metabolites | Draft GEM Reactions | Reactions After Validation with Carbon Data | Final Reactions |
|---|---|---|---|---|---|
| J2-031 | 770 (25.6%) | 1,112 | 1,053 | 1,219 | 1,320 |
| JO161 | 786 (26.0%) | 1,115 | 1,055 | 1,221 | 1,320 |
| J2-064 | 783 (26.7%) | 1,114 | 1,056 | 1,221 | 1,320 |
| R2-502 | 786 (25.6%) | 1,114 | 1,057 | 1,223 | 1,322 |
| F2365 | 780 (26.8%) | 1,110 | 1,053 | 1,219 | 1,318 |
| ScottA | 779 (25.8%) | 1,110 | 1,053 | 1,219 | 1,318 |
Enzymes catalyzing strain and serovar-specific metabolic reactions.
| Strain (Serovar) | Unique Enzymes |
|---|---|
| J2-031 (1/2a) | S-Adenosyl-L-homocysteine hydrolase |
| J2-064 (1/2b) | 4-hydroxybenzaldehyde:NAD+ oxidoreductase |
| F2365 (4b) | Adenosyl cobinamide kinase |
| J2-031 and JO161 (1/2a) | ATP:4-amino-5-hydroxymethyl-2-methylpyrimidine 5-phosphotransferase_c0 |
Number of strain and serovar specific nutrients.
| Carbon Sources | Nitrogen Sources | Sulfur + Phosphorus Sources | |
|---|---|---|---|
| All strains | 11 | 7 | 3 |
| No strains | 24 | 82 | 87 |
| Unique to J2-031 | 3 | 0 | 0 |
| Unique to JO161 | 4 | 0 | 0 |
| Unique to J2-064 | 1 | 0 | 0 |
| Unique to R2-502 | 3 | 0 | 1 |
| Unique to F2365 | 4 | 0 | 0 |
| Unique to ScottA | 0 | 1 | 0 |
| Unique to 1/2b | 1 | 1 | 2 |
Unique nutrient sources metabolized by a single L. monocytogenes strain or serovar.
| J2-031 | Formic Acid, D-Aspartic Acid, M-Tartaric Acid |
| JO161 | D-Melibiose, D-Threonine, Glyoxylic Acid, L-Serine |
| J2-064 | Glycyl-L-Proline |
| R2-502 | Adonitol, M-Inositol, L-Lyxose |
| F2365 | Sucrose, α-Hydroxy Glutaric Acid-γ-Lactone, Fumaric Acid, Tyramine |
| 1/2b | p-Hydroxy Phenyl Acetic Acid |
| ScottA | L-Threonine |
| 1/2b | D-Valine |
| R2-502 | 2-Hydroxyethane Sulfonic Acid |
| 1/2b | Thiosulfate, Tetrathionate |
Fig 1Comparison of in silico predictions to experimental results for 39 individual carbon sources.
The 39 carbon sources displayed are those with at least one disagreement.
Fig 2Comparison of in silico predictions to experimental results for 62 individual nitrogen sources.
Fig 3Comparison of in silico predictions to experimental results for 22 individual phosphorus sources.
Fig 4Comparison of in silico predictions to experimental results for 11 sulfur sources.
Fig 5Comparison of carbon source utilization agreement between this study and previous studies.
The carbon source utilization agreements of the six genome-scale metabolic models created in this study (green) are compared to the same agreements in 16 previously created models (blue).
Fig 6Comparison of nitrogen, phosphorus, and sulfur utilization agreement between this study and previous studies.
The nutrient utilization agreements of the six genome-scale metabolic models created in this study (dashed box) are compared to the same agreements in six previously created models for nitrogen (red), and four for phosphorus (green) and sulfur (purple).
Essential reaction summary for the simulation of conditions representing glucose minimal media, queso fresco, chicken breast, smoked salmon, cantaloupe, and romaine lettuce.
| Glucose Minimal Media | ||||
|---|---|---|---|---|
| Strain | Total (% Shared) | Unique (%) | Serovar | Serovar Specific Reactions |
| J2-031 | 369 (95.1%) | 7 (1.90%) | 1/2a | 3 |
| JO161 | 371 (94.6%) | 0 (0%) | ||
| J2-064 | 368 (95.4%) | 2 (0.54%) | 1/2b | 0 |
| R2-502 | 368 (95.4%) | 0 (0%) | ||
| F2365 | 367 (94.6%) | 1 (0.27%) | 4b | 0 |
| ScottA | 367 (95.6%) | 0 (0%) | ||
| J2-031 | 297 (93.6%) | 9 (3.03%) | 1/2a | 1 |
| JO161 | 295 (94.2%) | 0 (0%) | ||
| J2-064 | 306 (90.8%) | 7 (2.29%) | 1/2b | 0 |
| R2-502 | 294 (94.6%) | 0 (0%) | ||
| F2365 | 293 (94.9%) | 1 (0.34%) | 4b | 0 |
| ScottA | 293 (94.9%) | 0 (0%) | ||
| J2-031 | 297 (94.3%) | 7 (2.36%) | 1/2a | 1 |
| JO161 | 298 (94.0%) | 0 (0%) | ||
| J2-064 | 309 (90.6%) | 7 (2.27%) | 1/2b | 0 |
| R2-502 | 297 (94.3%) | 0 (0%) | ||
| F2365 | 296 (94.6%) | 1 (0.34%) | 4b | 0 |
| ScottA | 296 (94.6%) | 0 (0%) | ||
| J2-031 | 297 (94.3%) | 7 (2.36%) | 1/2a | 1 |
| JO161 | 298 (94.0%) | 0 (0%) | ||
| J2-064 | 309 (90.6%) | 7 (2.27%) | 1/2b | 0 |
| R2-502 | 297 (94.3%) | 0 (0%) | ||
| F2365 | 296 (94.6%) | 1 (0.34%) | 4b | 0 |
| ScottA | 296 (94.6%) | 0 (0%) | ||
| J2-031 | 295 (94.9%) | 5 (1.69%) | 1/2a | 1 |
| JO161 | 298 (94.0%) | 0 (0%) | ||
| J2-064 | 309 (90.6%) | 7 (2.27%) | 1/2b | 0 |
| R2-502 | 297 (94.3%) | 0 (0%) | ||
| F2365 | 296 (94.6%) | 1 (0.34%) | 4b | 0 |
| ScottA | 296 (94.6%) | 0 (0%) | ||
| J2-031 | 297 (94.3%) | 7 (2.36%) | 1/2a | 1 |
| JO161 | 298 (94.0%) | 0 (0%) | ||
| J2-064 | 309 (90.6%) | 7 (2.27%) | 1/2b | 0 |
| R2-502 | 297 (94.3%) | 0 (0%) | ||
| F2365 | 296 (94.6%) | 1 (0.34%) | 4b | 0 |
| ScottA | 296 (94.6%) | 0 (0%) | ||
Enzymes catalyzing strain and serovar-specific essential reactions in simulations reflecting glucose minimal media (MM), queso fresco (QF), chicken breast (CB), smoked salmon (SS), cantaloupe (C), or romaine lettuce (RL).
| Strain/Serovar | Unique Enzyme | MM | QF | CB | SS | C | RL |
|---|---|---|---|---|---|---|---|
| J2-031 | S-Adenosyl-L-homocysteine hydrolase | + | + | + | + | + | + |
| Oxalosuccinate:NADP+ oxidoreductase (decarboxylating) | - | + | - | - | - | - | |
| Isocitrate glyoxylate-lyase | + | + | + | + | + | + | |
| alpha-D-Glucose-1-phosphate:alpha-D-glucose-1-phosphate | + | + | + | + | + | + | |
| Xanthosine-5’-phosphate:L-glutamine amido-ligase (AMP-forming) | + | + | + | + | + | + | |
| Maltose:orthophosphate 1-beta-D-glucosyltransferase | + | + | + | + | - | + | |
| Adenosine:orthophosphate ribosyltransferase | + | + | + | + | + | + | |
| Isocitrate:NADP+ oxidoreductase (decarboxylating) | - | + | - | - | - | - | |
| beta-D-Glucose 1-phosphate 1,6-phosphomutase | + | + | + | + | - | + | |
| J2-064 | 4-hydroxybenzaldehyde:NAD+ oxidoreductase | + | + | + | + | + | + |
| ATP:thiamine phosphotransferase | + | + | + | + | + | + | |
| 2-Methyl-4-amino-5-hydroxymethylpyrimidine-diphosphate:4-methyl-5- | - | + | + | + | + | + | |
| ATP:4-amino-2-methyl-5-phosphomethylpyrimidine phosphotransferase | - | + | + | + | + | + | |
| 4-amino-2-methyl-5-phosphomethylpyrimidine synthetase | - | + | + | + | + | + | |
| thiazole phosphate synthesis | - | + | + | + | + | + | |
| 4-hydroxy-benzyl-alcohol dehydrogenase | - | + | + | + | + | + | |
| F2365 | Adenosyl cobinamide kinase | + | + | + | + | + | + |
| 1/2a | L-threonine ammonia-lyase_c0 | + | - | - | - | - | - |
| O-Acetyl-L-homoserine acetate-lyase (adding methanethiol)_c0 | + | - | - | - | - | - | |
| 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine:4-_c0 | + | + | + | + | + | + |
Experimentally determined conversion factors.
| Strain | Viable Cells (CFU/mL) to Biomass (gDCW/L) ± SD | OD600 to Biomass (gDCW/L) ± SD |
|---|---|---|
| J2-031 | --- | 1.27 x 10−1 ± 4.4 |
| JO161 | 2.8 x 10−10 ± 3.3 x 10−11 | 3.78 x 10−1 ± 2.17 x 10−1 |
| J2-064 | 4.4 x 10−11 ± 1.7 x 10−11 | 9.38 x 10−2 ± 4.79 x 10−2 |
| R2-502 | 1.3 x 10−10 ± 6.4 x 10−11 | 2.27 x 10−1 ± 8.7 |
| F2365 | 4.6 x 10−11 ± 1.2 x 10−11 | 8.19 x 10−2 ± 3.91 x 10−2 |
| ScottA | 4.3 x 10−11 ± 2.1 x 10−11 | 1.03 x 10−1 ± 7.60 x 10−2 |
a Standard Deviation
b Viable cell count was not taken for strain J2-031
Fig 7Comparison of experimental and in silico growth rates and growth yields including experimental standard deviations.
Nutrients added to essential reaction simulations to reflect high-risk foods.
| Nutrient | Queso Fresco | Chicken Breast | Smoked Salmon | Cantaloupe | Romaine Lettuce |
|---|---|---|---|---|---|
| L-Glutamate | + | + | + | + | + |
| Glycine | + | + | + | + | + |
| L-Lysine | + | + | + | + | + |
| L-Aspartate | + | + | + | + | + |
| L-Arginine | + | + | + | + | + |
| L-Glutamine | + | - | - | - | - |
| L-Serine | + | + | + | + | + |
| L-Methionine | + | + | + | + | + |
| L-Tryptophan | + | + | + | + | + |
| L-Phenylalanine | + | + | + | + | + |
| L-Tyrosine | + | + | + | + | + |
| Sucrose | - | - | - | + | - |
| D-Fructose | - | - | - | + | + |
| L-Cysteine | + | + | + | + | + |
| Choline | + | + | + | + | + |
| L-Leucine | + | + | + | + | + |
| D-Alanine | + | + | + | + | + |
| L-Histidine | + | + | + | + | + |
| L-Proline | + | + | + | + | + |
| L-Asparagine | + | - | - | - | - |
| L-Valine | + | + | + | + | + |
| L-Threonine | + | + | + | + | + |
| Maltose | - | - | - | + | - |
| Palmitate | + | + | + | + | + |
| Riboflavin | + | + | + | + | + |
| Thiamin | + | + | + | + | + |
| L-Isoleucine | + | + | + | + | + |
| Vitamin B12 | + | + | + | - | - |